Alnylam, Precision NanoSystems enter collaboration for discovery of novel small lipid nanoparticles

Precision NanoSystems, Inc. and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the two companies have formed an exclusive collaboration focused on the discovery and development of novel lipid nanoparticles, known as small lipid nanoparticles ("sLNPs"), using microfluidics technology. Based on their small particle size of approximately 20 nanometers, sLNPs have the potential for broadened biodistribution beyond liver delivery.

“sLNPs represent an exciting and innovative approach in Alnylam's advancement of proprietary LNPs for RNAi therapeutics.”

"We look forward to working with Precision NanoSystems to support research efforts around the discovery of novel sLNPs that we believe have the potential to significantly improve and broaden biodistribution," said Kenneth Koblan, Ph.D., Chief Scientific Officer at Alnylam. "sLNPs represent an exciting and innovative approach in Alnylam's advancement of proprietary LNPs for RNAi therapeutics."

"We are excited to have formed this exclusive collaboration with Alnylam focused on the discovery and development of novel sLNPs using microfluidics technology," said James Taylor, Ph.D., Chief Executive Officer of Precision NanoSystems. "Alnylam is leading the translation of RNAi technology into human therapeutics, and we look forward to working with them."

Source:

Alnylam's Pharmaceuticals

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Precision NanoSystems Inc.. (2019, June 17). Alnylam, Precision NanoSystems enter collaboration for discovery of novel small lipid nanoparticles. News-Medical. Retrieved on April 22, 2021 from https://www.news-medical.net/news/20110420/Alnylam-Precision-NanoSystems-enter-collaboration-for-discovery-of-novel-small-lipid-nanoparticles.aspx.

  • MLA

    Precision NanoSystems Inc.. "Alnylam, Precision NanoSystems enter collaboration for discovery of novel small lipid nanoparticles". News-Medical. 22 April 2021. <https://www.news-medical.net/news/20110420/Alnylam-Precision-NanoSystems-enter-collaboration-for-discovery-of-novel-small-lipid-nanoparticles.aspx>.

  • Chicago

    Precision NanoSystems Inc.. "Alnylam, Precision NanoSystems enter collaboration for discovery of novel small lipid nanoparticles". News-Medical. https://www.news-medical.net/news/20110420/Alnylam-Precision-NanoSystems-enter-collaboration-for-discovery-of-novel-small-lipid-nanoparticles.aspx. (accessed April 22, 2021).

  • Harvard

    Precision NanoSystems Inc.. 2019. Alnylam, Precision NanoSystems enter collaboration for discovery of novel small lipid nanoparticles. News-Medical, viewed 22 April 2021, https://www.news-medical.net/news/20110420/Alnylam-Precision-NanoSystems-enter-collaboration-for-discovery-of-novel-small-lipid-nanoparticles.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Horizon 2020 program selects Precision NanoSystems’ NanoAssemblr platform to develop RNA medicines